Literature DB >> 6841535

Determination of fluphenazine in plasma by high-performance thin-layer chromatography.

C M Davis, D C Fenimore.   

Abstract

Determination of fluphenazine in blood plasma by in situ fluorescent detection after separation by high-performance thin-layer chromatography is described. Enhancement of fluorescent emission of the drug is accomplished by exposure to UV light in the presence of paraffin oil which permits a limit of detectability of approximately 0.1 ng/ml in blood plasma. Thirty samples or more can be processed in a 7-h period with excellent precision (less than 3% relative standard deviation at 2.5 ng/ml). Investigation of extraction procedures, chromatographic conditions, photodevelopment, and fluorescent detection are described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841535     DOI: 10.1016/s0378-4347(00)86112-5

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Forced Degradation Behaviour of Fluphenazine Hydrochloride by LC and Characterization of its Oxidative Degradation Product by LC-MS/MS.

Authors:  Kashyap N Thummar; Dilip J Ghava; Anvi Mistry; Ashish Vachhani; Navin R Sheth
Journal:  Sci Pharm       Date:  2014-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.